Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia With Tozuleristide, a Fluorescent Tumor Marking Agent

NCT05316688 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05316688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05316688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia With Tozuleristide, a Fluorescent Tumor Marking Agent
Lead sponsor
University of Washington
Phase
Phase 1/2
Overall status
Terminated
Start date
April 17, 2024
Completion date
September 26, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cavity squamous cell carcinoma, stage i lip and oral cavity cancer ajcc v8, stage ii lip and oral cavity cancer ajcc v8, stage iii lip and oral cavity cancer ajcc v8, stage iva lip and oral cavity cancer ajcc v8